Based on pathological examinations of the brain in Alzheimer’s disease, two proteins, cyclin-dependent kinase 5 (Cdk5) and glycogen synthase kinase 3β (GSK3β), may be involved in the abnormal phosphorylation of tau [5,6]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.